Part B Drugs Could Be Switched To Part D Under Trump Pricing Plan

Bringing the hammer down on biopharma, HHS Secretary Azar says department could use demonstration projects to switch drugs from Medicare Part B to Part D.

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

Flaunting an aggressive tone against drugmakers and rising drug prices, Health and Human Services (HHS) Secretary Alex Azar suggested he will use administrative authority with his "very powerful pen" to move drugs from Medicare Part B into Medicare Part D, where private sector payers would negotiate the prices.

Speaking with reporters May 14, the Monday after President Trump's Friday speech on lowering drug prices, Azar admitted there are...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers